课题基金 / 基金详情

Functional Outcomes in Pediatric Liver Transplantation

Functional Outcomes in Pediatric Liver Transplantation
小儿肝移植的功能结果
批准号:
7614370
负责人:
Estella M. Alonso
金额:
$37.2万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2011-03-31

项目摘要

项目成果

Estella M. Alonso的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):我们广泛的、长期的目标是改善接受肝移植的儿童的预后。这项拟议研究的主要目标是在几个重要水平上检查这些患者的功能结果。首先,健康相关的生活质量(HRQOL)将通过儿科肝移植研究(SPLIT)医学结果研究进行前瞻性跟踪的大队列中进行测量。Split是一个由38个中心组成的行业资助的财团,成立于1995年,目的是追踪联合器官共享网络(UNOS)数据库没有记录的医疗结果。该数据库现在包括1308名接受了首次肝脏移植的儿童。一种经过充分验证的儿科仪器测量了其中800名儿童的HRQOL,并将其与正常人群进行比较。移植前后收集的医学变量和人口学信息将被用来建立一个预测HRQOL的模型,该模型可以作为改善移植后HRQOL的干预研究的基础。其次,一项关于智力、入学准备、学业成绩和行为的纵向研究将在按年龄定义的队列的子集中进行。大约有150名儿童将在5-6岁和两年后进行研究。测试电池将包括智商、阅读和算术技能、适应行为(日常生活技能)、组织技能和异常行为筛查。具体地说,这项研究将检验这一假设,即肝移植后儿童的功能结果低于正常儿童。预计HRQOL将随着移植间隔时间的延长而提高,但不会等同于正常人群。认知发育也同样会延迟,预计会与移植时的年龄、移植时的疾病敏锐度和医学并发症以及持续的医学残疾相关。这项多中心合作研究将由在结果和生活质量研究和发展评估方面具有专业知识的顾问提供支持。预计从这项研究中获得的信息将使临床医生能够确定优化结果的干预措施,并更好地向患者、家庭和临床医生通报肝移植后对儿童的功能期望。
英文摘要
DESCRIPTION (provided by the applicant): Our broad, long-term goals are to improve outcomes for children who undergo liver transplantation. The primary objectives of the proposed study are to examine functional outcome of these patients on several important levels. First, health-related quality of life (HRQOL) will be measured in a large cohort that has been followed prospectively through the Studies of Pediatric Liver Transplantation (SPLIT) medical outcomes study. SPLIT is an industry-funded consortium of 38 centers established in 1995 to follow medical outcomes not captured by the United Network for Organ Sharing (UNOS) database. The database now includes 1308 children who have received their first liver transplant. Responses from a well-validated, pediatric instrument measuring HRQOL in 800 of these children will be compared to a normative population. Medical variables and demographic information collected before and following transplantation will be used to develop a model, which predicts HRQOL and which could serve as the foundation for intervention studies to improve HRQOL after transplant. Second, a longitudinal study of intellectual ability, school readiness, academic achievement and behavior will be conducted in a sub-set of the cohort defined by age. Approximately, 150 children will be studied at 5-6 years of age and two years later. Testing batteries will include measures of intellectual quotient, reading and arithmetic skills, adaptive behavior (daily-living skills), organizational skills, and screening for abnormal behavior. Specifically, this study will test the hypothesis that functional outcome is lower for children after liver transplant than for normal children. It is expected that HRQOL will improve with interval from transplant, but will not be equal to a normative population. Cognitive development will likewise be delayed and is expected to correlate with age at transplant, acuity of illness and medical complications at the time of transplant and ongoing medical disability. This multi-center collaborative study will be supported by consultants with expertise in outcomes and quality of life research and developmental assessment. It is expected that information gained in this study will allow clinicians to identify interventions that optimize outcomes and better inform patients, families and clinicians about functional expectations for children after liver transplantation.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/petr.12126
发表时间: 2013-11
期刊: Pediatric transplantation
影响因子: 1.3
作者: [Alonso EM, Martz K, Wang D, Yi MS, Neighbors K, Varni JW, Bucuvalas JC, Studies of Pediatric Liver Transplantation (SPLIT) Functional Outcomes Group (FOG)]
通讯作者: Studies of Pediatric Liver Transplantation (SPLIT) Functional Outcomes Group (FOG)
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
Pediatric Acute Liver Failure (PALF) TReatment for ImmUne Mediated PathopHysiology (TRIUMPH)
Pediatric Acute Liver Failure (PALF) TReatment for ImmUne Mediated PathopHysiology (TRIUMPH)
海外基金